CDTOB
Castle Minerals Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Castle Minerals Limited - Option Expiring 07-Jan-2025
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.00
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in CDTOB
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in CDTOB
N/A
CDTOB investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in CDTOB also invest in...
Want more shares? Try these...
CardieX Ltd. engages in designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. The company specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.
🙌 Performance (5Yr p.a)
-13.38%
📊 Share price
$0.10 AUD
🩺 HEALTH CARE
Castle Minerals Ltd. engages in the exploration of mineral properties in Ghana, West Africa. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-05-02. The firm has interests in several projects in Ghana and Western Australia that are prospective for battery metals (graphite and lithium), base metals (zinc, lead, and copper) and gold. In Ghana, West Africa, the emerging flagship Kambale Graphite Project is owned by its Ghanaian subsidiary, Kambale Graphite Limited. Its Ghanaian subsidiary, Carlie Mining Ltd, holds a 2,686 square kilometers tenure position in the same Upper West region. Its projects in Western Australia include Earaheedy Basin project, Beasley Creek project, Polelle project, Wilgee Springs project, and Woodcutters project. The Earaheedy Basin project comprises the Withnell and Terra Rossa sub-projects. The Beasley Creek project is prospective for gold and lithium and lies on the northern flanks of the Rocklea Dome in the southern Pilbara. The Polelle project, about seven kilometers southeast of the operating Bluebird gold mine near Meekatharra.
🙌 Performance (5Yr p.a)
-12.50%
📊 Share price
$0.00 AUD
⛏️ MINING
